Acadesine for patients with relapsed/refractor... - CLL Support

CLL Support

22,475 members38,615 posts

Acadesine for patients with relapsed/refractory (CLL). Like fludarabine but very different.

Cllcanada profile image
CllcanadaTop Poster CURE Hero
2 Replies

Acadesine, , 5-aminoimidazole-4-carboxamide- 1-D-ribofuranoside or AICA-riboside, is a water soluble nucleoside with a different mechanism of action compared to currently approved nucleoside analogs (e.g., fludarabine).

Of importance...

Acadesine is not reliant on the p53 tumor suppressor or ataxia telangiectasia mutated (ATM) proteins to drive apoptosis, and hence, the absence/loss of function of these proteins in patients with CLL should not affect the activity of acadesine.

This is an important issue because alterations of either p53 or ATM are related to resistance to chemotherapy in CLL

link.springer.com/content/p...

Stay tuned...early days.

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
keepfit123 profile image
keepfit123

Acadesine sounds like another useful drug for CLL . Does the absence /loss of function of P.53 mean you are 17p deleted.

Cllcanada profile image
CllcanadaTop Poster CURE Hero

Yes and no...TP53 is a gene that encodes a tumor supressor protein called p53 and it is often deleted in 17p deletion...but some times it is mutated or disfunctional...it depend on the locus and size of the missing bit of chromosone...

more

asco.org/ASCOv2/Meetings/Ab...

You may also like...

Time-Limited Triplet Emerges as a Potential Standard in Relapsed/Refractory CLL

relapsed/refractory chronic lymphocytic leukemia (CLL) who have progressed on frontline BTK...

cll-patient-survival-improves

data at June ASCO:...

Nuvaxovid vaccine in patients with CLL

the Nuvaxovid vaccine? I wonder how people with CLL react to this vaccine. thanks for the answer.

Starting CAR-T therapy for my relapsing CLL

of the CLL Society, I decided it was best to again share details of my personal battle with CLL in...

CAR T was just approved for Relapsed/Refractory CLL/SLL ( Potentially 20% CURE rate)

fda-approval-of-liso-cel-in-relapsed-refractory-cll-sll